Bioscience

Clovis Oncology announces interim results for drug treating pancreatic cancer

Clovis Oncology announces interim results for drug treating pancreatic cancer

BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced interim results from an investigator-initiated Phase 2 trial of Rubraca (rucaparib) in platinum-sensitive patients with advanced... Read More

Tuesday April 2, 2019 0 comments Tags: Boulder, Clovis Oncology, Patrick J. Mahaffy, Rubraca

Flagship Biosciences partners with German company for global tissue diagnostics services

Flagship Biosciences partners with German company for global tissue diagnostics services

WESTMINSTER -- Flagship Biosciences and Germany-based Indivumed announced a partnership to expand their broad tissue-based biomarker development capabilities, as well as their clinical... Read More

Monday April 1, 2019 0 comments Tags: Westminster, Flagship Biosciences, Indivumed, Trevor Johnson

Haleigh’s Hope hemp extract receives first USDA Organic Certification

Haleigh’s Hope hemp extract receives first USDA Organic Certification

DENVER -- Haleigh's Hope, a whole-plant hemp extract containing naturally occurring cannabinoids, has received the first USDA Organic Certification for a vertically integrated hemp CBD product. ... Read More

Monday April 1, 2019 0 comments Tags: Denver, Haleigh's Hope, Jason Cranford

KromaTiD announces opening of new corporate headquarters in Longmont

KromaTiD announces opening of new corporate headquarters in Longmont

LONGMONT -- KromaTiD, Inc. today announced the opening of the companys new corporate headquarters inColorado'sBoulder Countybiotech hub. The new facility includes corporate offices as well... Read More

Thursday March 28, 2019 0 comments Tags: Longmont, KromaTid, Christopher Tompkins

AlloSource announces first patient enrolled in cartilage defect study

AlloSource announces first patient enrolled in cartilage defect study

CENTENNIAL -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it enrolled the first patient in a study titled A... Read More

Thursday March 21, 2019 0 comments Tags: Centennial, AlloSource, ProChondrix CR, Ross Wilkins

Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care

Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care

BOULDER -- Array BioPharma Inc. (NASDAQ: ARRY) announced the National Comprehensive Cancer Network(NCCN) has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to... Read More

Tuesday March 19, 2019 0 comments Tags: Boulder, Array BioPharma, Ron Squarer

AlloSource: Tests show two-year shelf life for ProChondrix CR product

AlloSource: Tests show two-year shelf life for ProChondrix CR product

CENTENNIAL -- AlloSource , a company dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced ProChondrix CR now has a two-year shelf life based... Read More

Wednesday March 13, 2019 0 comments Tags: AlloSource, Corey Stone, ProChondrix, Centennial

Zynex expands corporate HQ to handle growth

Zynex expands corporate HQ to handle growth

ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac... Read More

Wednesday March 13, 2019 0 comments Tags: Englewood, Zynex, Thomas Sandgaard